Toward improved selectivity in cancer chemotherapy: the Richard and Hinda Rosenthal Foundation Award Lecture.
D000818:Animals; D000970:Antineoplastic Agents / Q000008:administration & dosage*; D002268:Carboxypeptidases / Q000008:administration & dosage; D004351:Drug Resistance; D004359:Drug Therapy, Combination; D005472:Fluorouracil / Q000008:administration & dosage; D005492:Folic Acid / Q000378:metabolism; D005493:Folic Acid Antagonists / Q000008:administration & dosage; D006801:Humans; D002955:Leucovorin / Q000008:administration & dosage; D008727:Methotrexate / Q000008:administration & dosage / Q000378:metabolism; D009369:Neoplasms / Q000188:drug therapy* / Q000378:metabolism; D014500:Uracil Nucleotides / Q000008:administration & dosage
D000970:Antineoplastic Agents; D005493:Folic Acid Antagonists; D014500:Uracil Nucleotides; D005492:Folic Acid; D002268:Carboxypeptidases; D002955:Leucovorin; D005472:Fluorouracil; D008727:Methotrexate